http://web.archive.org/web/20130518083538id_/http://www.cnn.com:80/2012/11/27/health/generic-lipitor-recall

-- despite a recall , millions of people may continue taking a generic form of @entity4 that might contain specks of glass			0
@entity7 issued the recall at the retail level november 9 , directing pharmacies not to dispense contaminated lots of the drug , but gave no directions to patients who have the drug at home			1
it 's made for a confusing situation for patients taking @entity7 's atorvastatin , the generic form of @entity4			1
cholesterol drug recalled over glass concerns " patients are sandwiched between two groups who are being less than helpful : the @entity26 and @entity7 , " said @entity22 , editor of prescription drugs at @entity24			1
a @entity26 spokeswoman could n't explain why the recall did n't direct consumers to stop taking the drug even though patients might have received the contaminated pills			1
the spokeswoman , @entity34 , referred questions about the recall to @entity7 , which issued a one - paragraph statement on its website and did not return phone calls and e-mails from @entity0			2
the statement said that " select batches " of the medicine may contain " small glass particles approximately less than 1mm in size " and that the recall was being conducted " out of an abundance of caution			0
" it did not give consumers guidance about what to do with supplies of the drug at home			0
" in my recent memory , there has never been anything like this , " @entity22 said			0
" it makes my palms sweat just thinking about it			0
" advice to patients between 3 million and 4 million people take @entity7 's atorvastatin , according to @entity64 , senior managing director at @entity65			1
the company has over a 40 % share of the generic @entity4 market			0
one major pharmacy , @entity69 , is telling patients it will not exchange @entity7 atorvastatin for another brand , according to @entity73 , vice president of corporate communications for @entity69			1
" @entity7 , in conjunction with the @entity26 , has determined there are no safety concerns associated with continued use of atorvastatin in the patients ' possession , " a recorded message tells consumers who call @entity69			1
pharmacists at several @entity86 pharmacies said it was all right to keep taking already - filled prescriptions of @entity7 atorvastatin , but the company would exchange it for another brand at a customer 's request			1
@entity24 is advising consumers to take potentially contaminated medicine back to the pharmacy and request another brand , @entity22 said			0
a company with a history @entity7 , @entity98 's largest pharmaceutical company and the 12th largest generics maker in the world , has had quality problems in the past			2
the @entity26 has accused the company of " a pattern of systemic fraudulent conduct , " including taking shortcuts in crucial quality tests			2
so widespread and grave was the misbehavior that in 2008 the @entity26 barred @entity7 from importing 30 drugs into the @entity109			2
previously on @entity0 : @entity4 loses patent , goes generic			0

the drug maker issued a recall for atorvastatin , but gave no directions to users
@entity7 and the @entity26 " are being less than helpful , " an *observer* says
@entity69 and @entity86 *locations* are telling patients it 's ok to take the pills

@entity22:Gill
@entity7:Ranbaxy Pharmaceuticals
@entity0:CNN.com
@entity26:FDA
@entity34:Sarah Clark-Lynn
@entity24:Consumer Reports
@entity4:Lipitor
@entity69:Express Scripts
@entity86:CVS
@entity98:India
@entity109:United States
@entity64:Ross Muken
@entity65:ISI Group
@entity73:Brian Henry